$9.72 $0.09 per serving
Product analysis
Choline 500 mg offers an affordable way to support choline intake for normal liver fat handling and nerve function. Its nutritional role does not establish extra memory or focus benefits when intake is already adequate.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality56
Choline bitartrate identifies the main nutrient source. That form does not by itself establish an extra cognitive benefit, while other preparation details are limited.
Ingredient Transparency75
Listed amounts make basic serving comparisons possible. Choline bitartrate is named, but the declared material should not automatically be read as the same amount of nutrient choline.
Value For Money88
The choline comparison supports good value for the declared serving. A separate carbohydrate value judgment remains uncertain.
Customer Satisfaction89
Ratings show positive satisfaction across a large number of responses. The broad response provides a more established picture of satisfaction without establishing memory or liver benefits.
Product Focus83
The main role is filling a choline gap for normal nerve function and liver fat handling. The cognitive and focus uses do not establish extra enhancement after nutritional needs are met.
- Format
Tablet - Container
- 100 Tablet(s)
- Per serving
- $0.09
- Customer rating
- 4.7 · 6,028 ratings
Goals
Impact
Highest effect
Choline · 500 mg
Choline helps the liver handle and export fat, with nutritional relevance when choline intake is low. The declared 500 mg per serving provides a substantial nutritional amount. This does not establish faster removal of unspecified toxins in someone with adequate intake.
How this product is rated for Liver & Detox
Ingredient fit96
The relevant ingredients sit within a broader formula, so its overall focus extends beyond this goal. The declared amounts fully meet the comparison references; these references do not establish a clinically effective detoxification dose.
Goal fit
The relevant ingredients sit within a broader formula, so its overall focus extends beyond this goal.
Dose adequacy
The declared amounts fully meet the comparison references; these references do not establish a clinically effective detoxification dose.
Pathways59
The main biological connection is liver cell integrity and fat export. One mapped area reaches substantial coverage.
Depth
The strongest mapped connection concerns liver cell integrity and fat export; biological coverage does not itself demonstrate toxin removal.
Breadth
One biological area reaches substantial coverage in the supplied comparison. This indicates concentrated ingredient connections rather than demonstrated clearance of toxins.
Evidence86
Vitamin B4 (Choline) leads the evidence comparison. Specific exposure, nutritional status and preparation distinctions constrain claims about toxin clearance.
Evidence strength
Vitamin B4 (Choline) leads the supplied evidence comparison. The practical interpretation remains limited by the populations, preparations and outcomes described.
Studied preparation
The preparation is accepted in the supplied comparison, although this does not establish routine toxin removal or equivalence across all extracts.
Formulation logic100
The supplied findings identify no unmet partner requirement or configured conflict. Amount thresholds describe the comparison rather than proven detoxification effectiveness.
Partner coverage
The relevant ingredients have no unmet partner requirement in the supplied findings; combining them does not establish an additional detoxification benefit.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The counted ingredients pass the comparison’s minimum amount threshold, which is not proof of an effective toxin-removal dose.
Impact
Highest effect
Choline · 500 mg
Choline is an essential nutrient and a precursor for acetylcholine, a chemical involved in nerve signaling. These roles do not establish routine memory enhancement, and the supplied choline-bitartrate experiments in healthy young adults were negative. The 500 mg serving receives full amount recognition in the saved findings, without proving a cognitive benefit.
How this product is rated for Cognitive Support
Ingredient fit96
Choline is the sole assessed ingredient and receives full amount recognition.
Goal fit
The assessed ingredients are directed toward cognitive support.
Dose adequacy
The relevant declared amount reaches the full saved exposure comparison; this does not establish a proven cognitive dose.
Pathways59
Acetylcholine signaling is the only substantially represented area.
Depth
Acetylcholine signaling is the only substantially represented area.
Breadth
One cognitive area reaches substantial coverage, leaving the other areas unrepresented or less developed.
Evidence89
Choline-bitartrate findings do not establish routine cognitive enhancement.
Evidence strength
Choline-bitartrate findings do not establish routine cognitive enhancement.
Studied preparation
Choline meets the saved preparation comparison.
Formulation logic100
The assessed ingredients need no missing partner and meet the saved minimum amount comparison. No configured conflict was identified.
Partner coverage
The assessed ingredients work alone or have their required partner; no missing partner was identified.
Conflicts
No configured ingredient conflict was identified.
Effective doses
The assessed ingredients meet the saved minimum amount comparison, without establishing a proven cognitive benefit.
Impact
High effect
Choline · 500 mg
Choline is a precursor for acetylcholine, a messenger involved in attention. That normal role does not establish extra focus in adults with adequate intake, and the supplied healthy-adult choline-bitartrate trial did not show acute memory improvement. The declared bitartrate material should not be assumed equivalent to an amount of nutrient choline.
How this product is rated for Mental Focus
Ingredient fit96
Vitamin B4 (Choline) underpin this product’s connection to focus. The amounts meet the saved comparison range.
Goal fit
The relevant ingredients dominate the formula, although it is linked to several goals.
Dose adequacy
The included amounts reach the saved reference range; this is an amount comparison, not proof of a focus benefit.
Pathways60
The main mapped contribution is cholinergic signalling. The mechanism alone does not establish an acute focus benefit.
Depth
Cholinergic signalling is the strongest mapped route. That biological connection does not itself demonstrate acute focus improvement.
Breadth
The meaningful mapped contribution is concentrated in one route, with limited breadth across other aspects of focus.
Evidence74
The supplied evidence is limited for immediate everyday focus, despite the biological roles reflected in the saved findings.
Evidence strength
The leading ingredient supplies the evidence finding, but the supplied science does not establish routine acute focus enhancement.
Studied preparation
The included preparations match those accepted in the saved comparison; this does not extend the trials to different outcomes or populations.
Formulation logic100
The included ingredients have no identified configured conflict. No required partner is missing.
Partner coverage
No required partner is missing for the included ingredients.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The included ingredients meet the saved minimum amount threshold; that threshold is not a demonstrated effective dose for acute focus.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 Calorie(s) | |
Total Carbohydrates | 1 Gram(s) | |
Choline (Choline Bitartrate) | 500 mg |
Choline (Choline Bitartrate) · 500 mg OverallScore81
Each serving provides 500 mg of choline from choline bitartrate, a larger amount. The available ingredient information also flags additives.
How this ingredient is rated
Active Ingredient Quality & Bioavailability53
The identified source is choline bitartrate, a standard choline form.
Choline Form Efficacy & Bioavailability
The identified source is choline bitartrate, a standard choline form.
Formula Purity & Excipient Quality
The available ingredient information flags additives.
Dose, Safety & Label Transparency100
The stated amount is 500 mg of choline per serving.
Choline Dose by Declared Basis
A serving supplies 500 mg of choline, a larger amount.
Elemental Yield Transparency
The choline amount and its choline bitartrate source are identified.
Value100
At the whole-product price, the cost is about $0.02 per 100 mg of choline.
Price per 100 mg of Declared Choline Basis
The whole-product price corresponds to about $0.02 per 100 mg of choline.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
- Choline intake during pregnancy and child cognition at age 7 years.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
- Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
- Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease.
- Choline and Choline-Related Metabolites in Pediatric Short Bowel Syndrome.
- Choline Supplementation in Cystic Fibrosis-The Metabolic and Clinical Impact.
- 1H MR Spectroscopy at 3T for Hepatic Choline Quantification in Healthy Young Women: A Translational Imaging Study with Dietary Correlation.
- Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder.
- The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort.
- Association between Maternal Choline, Fetal Brain Development, and Child Neurocognition: Systematic Review and Meta-Analysis of Human Studies.
- Effect of Choline Supplementation on Neurological, Cognitive, and Behavioral Outcomes in Offspring Arising from Alcohol Exposure During Development: A Quantitative Systematic Review of Clinical and Preclinical Studies.
- Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.